Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX treatment in pediatric upper limb spasticity
2012-000062-38Phase 3Completed
- Sponsor
- Allergan
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in upper extremity spasticity and Muscle spasm (2 arms), sponsored by Allergan. Primary endpoints: Average grade change from baseline in MAS-B at weeks 4 and 6 and Average CGI by Physician score at weeks 4 and 6. Started Jul 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
upper extremity spasticityMuscle spasm
Beyond the preview
Go deeper on 2012-000062-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000062-38.